Prostatype Genomics AB (OSTO:PROGEN) Other Long Term Assets : kr3.80 Mil (As of Jun. 2023)

View and export this data going back to 2020. Start your Free Trial

What is Prostatype Genomics AB Other Long Term Assets?

Prostatype Genomics AB's other long-term assets for the quarter that ended in Jun. 2023 was kr3.80 Mil.

Prostatype Genomics AB's quarterly other long-term assets increased from Dec. 2022 (kr0.07 Mil) to Mar. 2023 (kr0.07 Mil) and increased from Mar. 2023 (kr0.07 Mil) to Jun. 2023 (kr3.80 Mil).

Prostatype Genomics AB's annual other long-term assets increased from Dec. 2021 (kr0.00 Mil) to Dec. 2022 (kr0.07 Mil) and increased from Dec. 2022 (kr0.07 Mil) to Dec. 2023 (kr0.07 Mil).

Prostatype Genomics AB Other Long Term Assets Historical Data

The historical data trend for Prostatype Genomics AB's Other Long Term Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Prostatype Genomics AB Other Long Term Assets Chart

Prostatype Genomics AB Annual Data

Trend

Jun18

Jun19

Dec21

Dec22

Dec23

Other Long Term Assets

0.02

0.07

Prostatype Genomics AB Quarterly Data
	Jun18	Jun19	Mar20	Jun20	Sep20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Dec23
Other Long Term Assets	Get a 7-Day Free Trial											0.07	0.07	0.07	3.80	0.07

Prostatype Genomics AB Other Long Term Assets Calculation

GuruFocus lists Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets under the "Total Long-Term Assets" section.

Other Long Term Assets includes following items:
Investment in Properties
Non-current Accounts Receivable
Non-current Note Receivables
Non-current Deferred Assets
Non-current Prepaid Assets
Defined Pension Benefit
Other (too numerous to list)
Some companies can do choose to report each of these items separately. Yet, there are a variety of Other Long Term Assets which are simply too numerous to list.

Prostatype Genomics AB (OSTO:PROGEN) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Prostatype Genomics AB (OSTO:PROGEN) » Definitions » Other Long Term Assets

Comparable Companies

Traded in Other Exchanges

PGO:Germany

Address

Gustaf III:s Boulevard 34, Solna, SWE, 169 73

Website

https://www.prostatypegenomics.com

Prostatype Genomics AB manufactures, markets and sells the prognostic gene test Prostatype. By assessing the aggressiveness of prostate cancer, Prostatype helps clinicians and patients to make correct treatment decisions. Over and under treatment of prostate cancer can be minimized, the quality of life for the patient improved and money can be saved for the health care sector.

Prostatype Genomics AB (OSTO:PROGEN) Headlines

No Headlines